Effectiveness and tolerability of first-line autologous stem cell transplant and maintenance rituximab for mantle cell lymphoma

被引：0
作者：
Falcone, Umberto [1 ,2 ]
Jiang, Haiyan [3 ]
Bashir, Shaheena [3 ]
Tsang, Richard [4 ]
Kukreti, Vishal [1 ,2 ]
Keating, Armand [1 ,2 ]
Crump, Michael [1 ,2 ]
Kuruvilla, John [1 ,2 ]
机构：
[1] Univ Toronto, Princess Margaret Canc Ctr, Dept Med Oncol & Hematol, Toronto, ON, Canada
[2] Univ Toronto, Dept Med, Toronto, ON, Canada
[3] Univ Toronto, Princess Margaret Canc Ctr, Dept Biostat, Toronto, ON, Canada
[4] Univ Toronto, Princess Margaret Canc Ctr, Radiat Med Program, Toronto, ON, Canada
来源：
BONE MARROW TRANSPLANTATION | 2018年 / 53卷 / 03期
关键词：
PROSPECTIVE RANDOMIZED-TRIAL; PLUS RITUXIMAB; FREE SURVIVAL; CYCLOPHOSPHAMIDE; CHEMOTHERAPY; SUPERIOR; THERAPY; CHOP;
D O I：
10.1038/s41409-017-0054-8
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：347 / 351
页数：5
相关论文
共 50 条
  • [31] Autologous stem cell transplantation (ASCT) in patients with mantle cell lymphoma: a retrospective study of the Spanish lymphoma group (GELTAMO)
    Garcia-Noblejas, A.
    Cannata-Ortiz, J.
    Conde, E.
    Gonzalez Barca, E.
    Gutierrez, N.
    Rojas, R.
    Vidal, M. J.
    Ramirez, M. J.
    Jimenez-Ubieto, A.
    Garcia-Ruiz, J. C.
    Sancho, J. M.
    Lopez, A.
    Rios Rull, P.
    Novelli, S.
    Albo, C.
    Deben, G.
    Lopez-Guillermo, A.
    Nicolas, C.
    Gonzalez de Villambrosia, S.
    Mercadal, S.
    Martin Garcia-Sancho, A.
    Arranz, R.
    ANNALS OF HEMATOLOGY, 2017, 96 (08) : 1323 - 1330
  • [32] Rituximab purging and maintenance therapy combined with autologous stem cell transplantation in patients with diffuse large B-cell lymphoma
    Zhang, Wei
    Jiao, Li
    Zhou, Dao-Bin
    Shen, Ti
    ONCOLOGY LETTERS, 2010, 1 (04) : 733 - 738
  • [33] Impact of rituximab maintenance and maintenance schedule on prognosis in first-line treatment of follicular lymphoma. Retrospective analysis from Czech Lymphoma Study Group (CLSG) database
    Janikova, Andrea
    Bortlicek, Zbynek
    Campr, Vit
    Kopalova, Natasa
    Benesova, Katerina
    Hamouzova, Jitka
    Belada, David
    Prochazka, Vit
    Pytlik, Robert
    Vokurka, Samuel
    Pirnos, Jan
    Duras, Juraj
    Mocikova, Heidi
    Mayer, Jiri
    Trneny, Marek
    LEUKEMIA & LYMPHOMA, 2016, 57 (05) : 1094 - 1103
  • [34] Cytomegalovirus infection in autologous stem cell transplant recipients in the era of rituximab
    Jain, Tania
    John, Jisha
    Kotecha, Aditya
    Deol, Abhinav
    Saliminia, Tanaz
    Revankar, Sanjay
    Chandrasekar, Pranatharthi
    ANNALS OF HEMATOLOGY, 2016, 95 (08) : 1323 - 1327
  • [35] Lenalidomide plus Rituximab as Initial Treatment for Mantle-Cell Lymphoma
    Ruan, Jia
    Martin, Peter
    Shah, Bijal
    Schuster, Stephen J.
    Smith, Sonali M.
    Furman, Richard R.
    Christos, Paul
    Rodriguez, Amelyn
    Svoboda, Jakub
    Lewis, Jessica
    Katz, Orel
    Coleman, Morton
    Leonard, John P.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (19) : 1835 - 1844
  • [36] Maintenance rituximab in newly diagnosed mantle cell lymphoma patients: a real world analysis from the Czech lymphoma study group registry†
    Obr, Ales
    Prochazka, Vit
    Papajik, Tomas
    Klener, Pavel, Jr.
    Janikova, Andrea
    Salek, David
    Belada, David
    Pytlik, Robert
    Sykorova, Alice
    Mocikova, Heidi
    Simkovic, Martin
    Campr, Vit
    Dlouha, Jitka
    Furst, Tomas
    Trneny, Marek
    LEUKEMIA & LYMPHOMA, 2019, 60 (03) : 748 - 755
  • [37] The Mantle Cell Lymphoma International Prognostic Index (MIPI) is superior to the International Prognostic Index (IPI) in predicting survival following intensive first-line immunochemotherapy and autologous stem cell transplantation (ASCT)
    Geisler, Christian H.
    Kolstad, Arne
    Laurell, Anna
    Raty, Riikka
    Jerkeman, Mats
    Eriksson, Mikael
    Nordstrom, Marie
    Kimby, Eva
    Boesen, Anne Marie
    Nilsson-Ehle, Herman
    Kuittinen, Outi
    Lauritzsen, Grete F.
    Ralfkiaer, Elisabeth
    Ehinger, Mats
    Sundstrom, Christer
    Delabie, Jan
    Karjalainen-Lindsberg, Marja-Liisa
    Brown, Peter
    Elonen, Erkki
    BLOOD, 2010, 115 (08) : 1530 - 1533
  • [38] Front-line treatment of mantle cell lymphoma
    Geisler, Christian H.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (08): : 1241 - 1243
  • [39] Autologous and allogeneic stem cell transplantation: rising therapeutic promise for mantle cell lymphoma
    Tam, Constantine S.
    Khouri, Issa F.
    LEUKEMIA & LYMPHOMA, 2009, 50 (08) : 1239 - 1248
  • [40] Autologous hematopoietic stem cell transplantation as first-line consolidation therapy can improve the prognosis of diffuse large B-cell lymphoma with high expression of MYC protein
    Hu, Kai
    Gao, Jin-Jie
    Li, Qi-Hui
    Tian, Lei
    Wan, Wei
    Zhao, Wei
    Wang, Ji-Jun
    Fu, Lin
    KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2019, 35 (07) : 425 - 431
12345